BioSpace News Archive

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Sarah Cannon Research Institute (Sarah Cannon) announced today that the first patient has been dosed in the first-in-human phase 1 study evaluating DS-6000, a CDH6 directed antibody drug conjugate (ADC), in patients with advanced renal cell carcinoma or ovarian cancer with disease progression following standard treatment.

Artelo Biosciences, Inc. (NASDAQ: ARTL) today embarks on a collaboration with researchers from Trinity College Dublin to investigate pre-clinical models of human cancer cachexia, a wasting syndrome that affects up to 80% of all cancer patients and is believed to hasten death in this population.

EncrypGen, the world’s first blockchain-mediated genomic DNA data marketplace, applauds CBS “60 Minutes” for its segment, “The Big Money Market for Your DNA,” examining the global DNA data market and highlighting existing business models that may result in the exploitation of consumer DNA data.

China Jo-Jo Drugstores, Inc., a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, released a letter to shareholders from the Chairman of the Company’s board of directors.

Nanomedic Technologies, a leader in Electrospun Healing Fiber (EHF™) technology for wound healing and skin regeneration, today announced that Rambam Health Care Campus, the primary hospital for northern Israel, has selected the Spincare Wound Care System to enhance patient care and improve its ability to heal wounds and burns

Dyadic International, Inc. (“Dyadic”) (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs, and improve the performance of vaccines, drugs and other biological products at flexible commercial scales, today announced a fully funded collaboration with TurtleTree Scientific

Inovytec, an innovator of multi-functional and user-friendly critical medical devices, announced today that it was granted FDA 510(k) clearance to market and sell its Ventway Sparrow ventilators in the United States.

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”) today announced the addition of two new executives to the company’s management team. Industry veteran Brian Leuthner has been appointed as OncoSec’s Chief Operating Officer and Joe Smith has joined as Vice President of Business Development

Blink Science, Inc., a global company that is revolutionizing point-of-care medical diagnostics and data systems, will lead global initiatives to unify medical passports.

NeuroVision Imaging Inc., announced today it has received an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to support developing reliable, affordable biomarker tests for Alzheimer’s disease and other forms of dementia and neurodegenerative disorders.